you are here: Home News Thyrocare

Thyrocare

Thyrocare promoter Docon Technologies sells 10% stake for Rs 668 crore; stock up 1.6%
Thyrocare's Velumani urges recruiters to hire poor and humble employees 'for long term success'
'Troll me as much as you enjoy': Thyrocare CEO after post on riding OLA cabs instead of luxury cars
Thyrocare shares jump 6% after firm's Q3 net profit rises 24% to Rs 19 crore
PharmEasy co-founders Dharmil Sheth, Dhaval Shah, Harsh Parekh and Hardik Dedhia to leave troubled startup
Thyrocare Q3 results: Net profit flat at Rs 14.74crore
Diagnostics players have become rational in terms of pricing: Thyrocare CEO
Thyrocare Q2 results: Net profit up 31.75% to Rs 20.33 crore
Stock Market Live: Covid Fears Hurting Markets. Will The Selloff Continue? RIL, Thyrocare In Focus
Stock Market Live: Diagnostics Stocks Back In Limelight Amid Covid Fears. Can The Momentum Sustain?
Discovery series: Is it time to start looking at this quality diagnostic service?
Stock Market Live: Nifty below 17,350 – more correction likely? Thyrocare, BLS and Orient Cement in focus
Thyrocare founder wants to invest 'minimum Rs 100 crore' in goat farming business
Thyrocare unveils new brand identity with a change in logo
Thyrocare boss recalls how he was asked to compare himself to fallen Silicon Valley star Elizabeth Holmes
Dr Lal Pathlab – Suburban Diagnostic deal - a marriage made in a Petri dish
PharmEasy raises $350 million in pre-IPO round: Report
Vijaya Diagnostic: What does this regional player offer amid industry consolidation?
Trend of omni-channel transactions like PharmEasy-Thyrocare here to stay, says ace dealmaker Sourav Mallik of Kotak
Emotional Dr Velumani says he “moved fast for a change” as he sold Thyrocare to PharmEasy
Pharmeasy raises additional $300 million from investors, aims for IPO in 6-18 months
PharmEasy to acquire 66.1% stake in Thyrocare for Rs 4,546 crore
Exclusive | PharmEasy in talks to acquire Thyrocare for Rs 7,000 crore
Exclusive | PharmEasy in talks to buy Thyrocare for around Rs 7,000 crore
Emerging healthcare trends put diagnostics sector in a sweet spot, IIFL Sec recommends buy on Metropolis, Thyrocare

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Thyrocare

Thyrocare promoter Docon Technologies sells 10% stake for Rs 668 crore; stock up 1.6%

Thyrocare's Velumani urges recruiters to hire poor and humble employees 'for long term success'

'Troll me as much as you enjoy': Thyrocare CEO after post on riding OLA cabs instead of luxury cars

Thyrocare shares jump 6% after firm's Q3 net profit rises 24% to Rs 19 crore

PharmEasy co-founders Dharmil Sheth, Dhaval Shah, Harsh Parekh and Hardik Dedhia to leave troubled startup

Thyrocare Q3 results: Net profit flat at Rs 14.74crore

Diagnostics players have become rational in terms of pricing: Thyrocare CEO

Thyrocare Q2 results: Net profit up 31.75% to Rs 20.33 crore

Stock Market Live: Covid Fears Hurting Markets. Will The Selloff Continue? RIL, Thyrocare In Focus

Stock Market Live: Diagnostics Stocks Back In Limelight Amid Covid Fears. Can The Momentum Sustain?

Discovery series: Is it time to start looking at this quality diagnostic service?

Stock Market Live: Nifty below 17,350 – more correction likely? Thyrocare, BLS and Orient Cement in focus

Thyrocare founder wants to invest 'minimum Rs 100 crore' in goat farming business

Thyrocare unveils new brand identity with a change in logo

Thyrocare boss recalls how he was asked to compare himself to fallen Silicon Valley star Elizabeth Holmes

Dr Lal Pathlab – Suburban Diagnostic deal - a marriage made in a Petri dish

PharmEasy raises $350 million in pre-IPO round: Report

Vijaya Diagnostic: What does this regional player offer amid industry consolidation?

Trend of omni-channel transactions like PharmEasy-Thyrocare here to stay, says ace dealmaker Sourav Mallik of Kotak

Emotional Dr Velumani says he “moved fast for a change” as he sold Thyrocare to PharmEasy

Pharmeasy raises additional $300 million from investors, aims for IPO in 6-18 months

PharmEasy to acquire 66.1% stake in Thyrocare for Rs 4,546 crore

Exclusive | PharmEasy in talks to acquire Thyrocare for Rs 7,000 crore

Exclusive | PharmEasy in talks to buy Thyrocare for around Rs 7,000 crore

Emerging healthcare trends put diagnostics sector in a sweet spot, IIFL Sec recommends buy on Metropolis, Thyrocare